Procter & Gamble Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has informed the exchanges that the trading window for its Directors and designated employees will be closed from October 1, 2025 until 48 hours after the publication of the unaudited financial results for the quarter ended September 30, 2025. This is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015. The Q2 FY2026 results are expected to be announced sometime after September 30, 2025, though no exact date has been mentioned in this filing.
This is a standard regulatory filing with no material impact on the stock price. It simply prevents insiders from trading in company shares ahead of the upcoming quarterly results announcement.